These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18676734)

  • 1. Moving toward individualized cancer therapies.
    Tonon G; Anderson KC
    Clin Cancer Res; 2008 Aug; 14(15):4682-4. PubMed ID: 18676734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.
    Glinsky GV
    J Clin Oncol; 2008 Jun; 26(17):2846-53. PubMed ID: 18539963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer biology: signatures guide drug choice.
    Downward J
    Nature; 2006 Jan; 439(7074):274-5. PubMed ID: 16421553
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer pharmacogenetics.
    Marsh S
    Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enabling personalized cancer medicine through analysis of gene-expression patterns.
    van't Veer LJ; Bernards R
    Nature; 2008 Apr; 452(7187):564-70. PubMed ID: 18385730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OPG is regulated by beta-catenin and mediates resistance to TRAIL-induced apoptosis in colon cancer.
    De Toni EN; Thieme SE; Herbst A; Behrens A; Stieber P; Jung A; Blum H; Göke B; Kolligs FT
    Clin Cancer Res; 2008 Aug; 14(15):4713-8. PubMed ID: 18676739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genes versus cancer.
    Lewis R
    Nature; 2007 Apr; 446(7137):826-7. PubMed ID: 17460827
    [No Abstract]   [Full Text] [Related]  

  • 8. Genomic medicines for oncology: early lessons.
    Simons JW
    J Med Assoc Ga; 2003; 92(1):35-8. PubMed ID: 12743904
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing in cancer therapeutics.
    Ezzeldin HH; Diasio RB
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4137-41. PubMed ID: 16857783
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.
    Dawood S
    Cancer Invest; 2009 Oct; 27(8):809-15. PubMed ID: 19731103
    [No Abstract]   [Full Text] [Related]  

  • 11. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and cancer treatment: weighing the evidence.
    Griggs JJ; Sabel MS
    J Clin Oncol; 2008 Sep; 26(25):4060-2. PubMed ID: 18757320
    [No Abstract]   [Full Text] [Related]  

  • 13. TRAIL as a target in anti-cancer therapy.
    Wu GS
    Cancer Lett; 2009 Nov; 285(1):1-5. PubMed ID: 19299078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis and non-apoptotic deaths in cancer development and treatment response.
    de Bruin EC; Medema JP
    Cancer Treat Rev; 2008 Dec; 34(8):737-49. PubMed ID: 18722718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Childhood ALL researchers focus on high-risk patients.
    Friedrich MJ
    J Natl Cancer Inst; 2009 May; 101(10):702-4. PubMed ID: 19436027
    [No Abstract]   [Full Text] [Related]  

  • 16. The person in personalised medicine.
    Doz F; Marvanne P; Fagot-Largeault A
    Eur J Cancer; 2013 Mar; 49(5):1159-60. PubMed ID: 23265710
    [No Abstract]   [Full Text] [Related]  

  • 17. Over-expression of clusterin is a resistance factor to the anti-cancer effect of histone deacetylase inhibitors.
    Liu T; Liu PY; Tee AE; Haber M; Norris MD; Gleave ME; Marshall GM
    Eur J Cancer; 2009 Jul; 45(10):1846-54. PubMed ID: 19342222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A checklist for evaluating reports of expression profiling for treatment selection.
    Simon R
    Clin Adv Hematol Oncol; 2006 Mar; 4(3):219-24. PubMed ID: 16728933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives.
    Nannini M; Pantaleo MA; Maleddu A; Astolfi A; Formica S; Biasco G
    Cancer Treat Rev; 2009 May; 35(3):201-9. PubMed ID: 19081199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized therapy in non-small-cell lung cancer: future versus current clinical practice.
    Pérez-Soler R
    Oncogene; 2009 Aug; 28 Suppl 1():S38-45. PubMed ID: 19680295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.